The National Agency for the Safety of Medicines informs 1.6 million women using desogestrel-based contraceptives of a slightly increased risk of meningioma, although considered low. Patients are advised to consult a doctor if they experience specific symptoms. ANSM emphasizes the necessity of not interrupting their treatment without medical advice to avoid an unwanted pregnancy.